Baofei Jiang
Impact in
- Cancer Research top 10%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Gastroenterology top 10%
Papers in
-
- RNA modifications and cancer 4
- RNA Research and Splicing 3
- Circular RNAs in diseases 3
-
- Cancer-related molecular mechanisms research 5
- MicroRNA in disease regulation 3
- Co-authors
- Xiaofei Zhi (3 shared papers)Qilong Wang (4 shared papers)Zengliang Li (2 shared papers)Zekuan Xu (2 shared papers)Li Yang (2 shared papers)Hao Xu (2 shared papers)Chao Luo (2 shared papers)Li Zhang (2 shared papers)
- Journals
- Scientific Reports (1 paper)Cell Death Discovery (1 paper)Oncology Reports (1 paper)FEBS Letters (1 paper)Medical Oncology (1 paper)
- Partner nations
- ChinaUnited StatesDenmark
In The Last Decade
Baofei Jiang
18 papers receiving 479 citations
Peers
Comparison fields: 5 of 82
- Cancer Research 200
- Gastroenterology 31
- Molecular Biology 315
- Biomaterials 42
- Oncology 69
Countries citing papers authored by Baofei Jiang
This map shows the geographic impact of Baofei Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Baofei Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Baofei Jiang more than expected).
Fields of papers citing papers by Baofei Jiang
This network shows the impact of papers produced by Baofei Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Baofei Jiang. The network helps show where Baofei Jiang may publish in the future.
Co-authors
The 25 scholars most cited alongside Baofei Jiang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 93 | |
| 2 | 2019 | 57 | |
| 3 | 2014 | 49 | |
| 4 | 2018 | 43 | |
| 5 | 2017 | 35 | |
| 6 | 2020 | 31 | |
| 7 | 2017 | 29 | |
| 8 | 2016 | 25 | |
| 9 | 2019 | 25 | |
| 10 | 2021 | 22 | |
| 11 | 2018 | 22 | |
| 12 | 2021 | 16 | |
| 13 | 2019 | 15 | |
| 14 | 2023 | 12 | |
| 15 | 2022 | 5 | |
| 16 | 2011 | 1 | |
| 17 | 2023 | 1 | |
| 18 | 2022 | 1 | |
| 19 | 2025 | 0 | |
| 20 | 2025 | 0 |
About Baofei Jiang
Baofei Jiang is a scholar working on Molecular Biology, Cancer Research, Surgery, Pulmonary and Respiratory Medicine and Oncology, having authored 20 papers that have together received 482 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (4 papers), MicroRNA in disease regulation (3 papers), Nanoparticle-Based Drug Delivery (3 papers), RNA Research and Splicing (3 papers), Circular RNAs in diseases (3 papers), Colorectal Cancer Treatments and Studies (2 papers) and Ferroptosis and cancer prognosis (2 papers). The work is most often cited by research in Cancer Research (200 citations), Gastroenterology (31 citations), Molecular Biology (315 citations), Biomaterials (42 citations) and Oncology (69 citations). Baofei Jiang has collaborated with scholars based in China, United States and Denmark. Frequent co-authors include Xiaofei Zhi, Qilong Wang, Zengliang Li, Zekuan Xu, Li Yang, Hao Xu, Chao Luo, Li Zhang, Yi Zhu and Ting Xu. Their work appears in journals such as Scientific Reports, Cell Death Discovery, Oncology Reports, FEBS Letters and Medical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.